Table 2.

Correlations between synovial biomarker expression and clinical measure of disease. All other correlations are not significant.

ComparisonCorrelation, rSignificance, p
C5a 16 weeks–DAS28 12 weeks0.5430.022
C5a 16 weeks–DAS28 52 weeks0.5390.029
CD20 baseline–DAS28 52 weeks0.4780.049
CD20 16 weeks–DAS28 12 weeks0.5740.016
OPN 16 weeks–DAS28 52 weeks−0.5700.022
  • DAS28: Disease Activity Score at 28 joints; OPN: osteopontin.